Single‐ and multiple‐dose pharmacokinetics and safety of pimodivir, a novel, non‐nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open‐label study in healthy volunteers
2018 ◽
Vol 84
(11)
◽
pp. 2663-2672
◽
Sofie Deleu
◽
Thomas N. Kakuda
◽
Kurt Spittaels
◽
Jurgen J. Vercauteren
◽
Vera Hillewaert
◽
...
Yue Hu
◽
Haijun Li
◽
Min Wu
◽
Hong Zhang
◽
Yanhua Ding
◽
...
2013 ◽
Vol 73
(1)
◽
pp. 103-111
◽
J. F. Grippo
◽
W. Zhang
◽
D. Heinzmann
◽
K. H. Yang
◽
J. Wong
◽
...
2008 ◽
Vol 69
(4)
◽
pp. 318-333
◽
Xing Zeng
◽
Yi Feng
◽
Liu Yang
◽
Yu Huang
◽
Dan Zhou
◽
...
2018 ◽
Vol 8
(1)
◽
pp. 87-94
Ana RuizαGarcia
◽
Nagdeep Giri
◽
Robert R. LaBadie
◽
Grace Ni
◽
Tanya Boutros
◽
...
2008 ◽
Vol 4
◽
pp. T792-T793
Antonia Periclou
◽
Yiqun Hu
2021 ◽
pp. molcanther.0985.2020
Michael S. Gordon
◽
John Nemunaitis
◽
Minal Barve
◽
Zev A. Wainberg
◽
Erika P. Hamilton
◽
...
Wan-Hong Zhao
◽
Jie Liu
◽
Bai-Yan Wang
◽
Yin-Xia Chen
◽
Xing-Mei Cao
◽
...
2018 ◽
Vol 20
(suppl_6)
◽
pp. vi20-vi20
Daniela A Bota
◽
Santosh Kesari
◽
David Piccioni
◽
Dawit Aregawi
◽
Patrick Roth
◽
...
Close
Export Citation Format
Close
Share Document
Close